NOVAVAX INC, S-3, EX-23.2, 2001-01-04

NOVAVAX INC
S-3, EX-23.2, 2001-01-04
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Previous: NOVAVAX INC, S-3, EX-23.1, 2001-01-04

Next: SOUTHLAND SEPARATE ACCOUNT L1, 497, 2001-01-04



<PAGE>   1
                                                                   EXHIBIT 23.2


                       CONSENT OF INDEPENDENT ACCOUNTANTS


         We hereby consent to the incorporation by reference in this
Registration Statement of Novavax, Inc. on Form S-3 of our report dated October
20, 2000, relating to the combined financial statements of Fielding
Pharmaceutical Company and MB Packaging, Inc., which appears in the Current
Report on Form 8-K/A of Novavax, Inc. dated December 18, 2000.

/s/ PricewaterhouseCoopers LLP
------------------------------
PricewaterhouseCoopers LLP

McLean, Virginia
January 3, 2001